Company: MDCXW
Filing Date: 2025-07-23
Form Type: 424B3
Source: 0001062993-25-013080
Chunk: 3

Company: Medicus Pharma Ltd.
Filing Date: 2025-07-23
Form: 424B3
Chunk 3
---
 |     | 10,115,364 |     |   17,311 |     | N/A     |     |        3,185,015 |
| Robert J. Ciaruffoli        |     | 10,115,639 |     |   17,036 |     | N/A     |     |        3,185,015 |
| Barry Fishman               |     | 10,115,314 |     |   17,361 |     | N/A     |     |        3,185,015 |
| Dr. Larry Kaiser            |     | 10,115,169 |     |   17,506 |     | N/A     |     |        3,185,015 |
| Dr. Sara R. May             |     | 10,115,569 |     |   17,106 |     | N/A     |     |        3,185,015 |
| Hon. Cathy McMorris Rodgers |     | 10,115,039 |     |   17,636 |     | N/A     |     |        3,185,015 |
| Ajay Raju                   |     | 10,116,519 |     |   16,156 |     | N/A     |     |        3,185,015 |

Proposal 3. Shareholders approved the proposal to amend Article 3.2 of the Company's by-laws to replace the reference to "10%" with a reference to "33⅓%" to comply with the corporate governance rules of Nasdaq requiring the Company, having ceased to be a foreign private issuer, to have a quorum requirement for the transaction of business at a meeting of shareholders of not less than 33⅓% of the outstanding shares of a Company's common voting stock. Shareholder approval of this Proposal 3 required the affirmative vote of at least a majority of the votes cast by the shareholders present at the Meeting in person or by proxy:

| For        |     | Against |     | Abstain |     | Broker Non-Votes |
| 10,127,547 |     |   5,128 |     | N/A     |     |        3,185,015 |

Proposal 4. Shareholders approved, in accordance with Nasdaq Listing Rule 5635(d), the issuance, sale and delivery by the Company pursuant to the Standby Equity Purchase Agreement dated February 10, 2025